Officials say mix-and-match vaccine trials to start soon cnnphilippines.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnnphilippines.com Daily Mail and Mail on Sunday newspapers.
The more than 1,200 cases of myocarditis or heart inflammation logged in the United States among young adults and adolescents following the inoculation of Pfizer vaccines should not prod the government to stop the use of the US-made jabs, the Philippine Council for Health Research and Development (P
There is no reason to stop the inoculation using American-made Pfizer vaccines in the Philippines even as there are newly-reported side effects for using the COVID-19 jabs, an official of the Department of Science and Technology (DOST) said Sunday. This after reports from US Food and Drug Administration (FDA) issued a warning about rare cases of myocarditis or heart inflammation among young adults and adolescents after vaccination using Moderna.
Published June 27, 2021, 2:37 PM
The “preliminary” results of the clinical trials on the use of the Virgin Coconut Oil (VCO), and lagundi (Chinese chaste tree) as a coronavirus disease (COVID-19) therapeutic or supplement could be expected by next month, an official of the Philippine Council for Health Research and Development (PCHRD) of the Department of Science and Technology (DOST-PCHRD) said on Sunday, June 27.
Virgin coconut oil (upper photo), Tawa-tawa (lower left), Lagundi (lower right) (MANILA BULLETIN FILE PHOTOS)
DOST-PCHRD Executive Director Dr. Jaime C. Montoya said the VCO clinical trial at the Philippine General Hospital (PGH) will be completed by end of this month and the initial analysis of the data is expected to be conducted, while the project team handling the lagundi clinical trials is currently conducting their data analysis.
Almost 250K Moderna COVID-19 vaccine doses arrive in Philippines gmanetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gmanetwork.com Daily Mail and Mail on Sunday newspapers.